Ethereum News Update: Crypto’s Political Bet: Trump’s Clemency and $263M in Lobbying Fuel Regulatory Ambiguity
- Ethereum led $522M in crypto liquidations as ETF inflows ($246M) surpassed Bitcoin for first time, signaling institutional adoption shifts. - Crypto groups spent $263M lobbying 2026 U.S. elections, doubling 2024 efforts, while Trump's Binance pardon boosted XRP, ETH, and BTC prices. - Trump Organization's crypto income surged 17-fold to $864M via token sales, raising ethical concerns amid UK money laundering probes into linked partners. - CLARITY Act faces 20% passage chance by 2026 deadline despite clos
Within the 24 hours ending on October 29, 2025, the global cryptocurrency market experienced liquidations totaling $522 million.
The uptick in ETF activity reflects a broader pattern of political and regulatory shifts influencing the industry. Crypto advocacy groups have assembled a $263 million fund for the 2026 U.S. midterm elections, nearly twice their 2024 expenditure and exceeding the lobbying budgets of the oil and gas sector, as reported by
At the same time, the
Despite these shifts, regulatory ambiguity remains. Bipartisan lawmakers are working to pass the CLARITY Act before a February 2026 deadline, as reported by
Amid these changes, the recent wave of liquidations underscores the dangers of leveraged trading. Ethereum’s leading role in liquidations—driven by its price falling to $4,010—illustrates the persistent challenges of volatility management, as Coinotag highlighted. Nevertheless, projects such as Blazpay are leveraging the current momentum.
As the industry continues to navigate evolving regulations, political dynamics, and market trends, the balance between institutional investment and speculative trading is expected to shape the course of 2026.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Solana News Update: Investors Rush to Solana Staking ETF While Competing Altcoins Falter
- Bitwise's Solana Staking ETF (BSOL) surged to $69.5M in debut-day inflows, the highest among 850+ 2025 ETFs. - BSOL's $288.92M AUM (0.01% of Solana's $107.4B cap) outperformed stagnant Litecoin/Hedera ETFs with 7.3% staking yields. - SEC's pre-shutdown rule accelerated approval, but NYSE Arca delayed U.S. listing until October 27 amid Hong Kong's first Solana ETF. - JPMorgan forecasts $3-6B in first-year inflows for staking ETFs as VanEck/Grayscale await approvals and Solana price fluctuates post-EFT lau

BNB News Today: Making U.S. Markets More Accessible: Ondo and Chainlink Broaden Global Investment Opportunities
- Ondo Finance partners with Chainlink to integrate real-time pricing and cross-chain interoperability for its tokenized equities platform. - The expansion to BNB Chain enables 24/7 global access to U.S. markets, with $320M+ TVL across 10 blockchains. - Chainlink's ACE ensures real-time compliance, while CCIP facilitates institutional cross-chain asset transfers tested with Swift and DTCC. - The collaboration bridges traditional finance and blockchain, accelerating RWA adoption through enhanced transparenc

EURAU Expands to Multiple Blockchains: AllUnity and Chainlink Address Liquidity Fragmentation Across Europe
- AllUnity partners with Chainlink to enable cross-chain EURAU stablecoin payments via CCIP, addressing European liquidity fragmentation in digital assets. - EURAU, MiCAR-compliant and issued on Ethereum, Solana, and Polygon, ensures 1:1 parity and institutional-grade liquidity across 6+ blockchains. - CEO Alexander Höptner highlights this as a milestone for secure, interoperable financial infrastructure in Europe's tokenized finance ecosystem. - MiCAR-driven trends see Swiss Relai and Circle's USDC expand

Shareholders Reject All-Stock Merger, Support Core Scientific's Shift to AI
- Core Scientific shareholders rejected a $9B all-stock merger with CoreWeave, boosting CORZ shares 5% while CRWV fell 6%. - Critics including Two Seas Capital and Van Eck opposed the deal, citing undervaluation and risks from CoreWeave's volatile equity. - Analysts now see standalone potential for Core Scientific, with Roth Capital upgrading it to "Buy" amid rising AI infrastructure demand. - The vote highlights growing skepticism toward all-stock mergers in speculative AI sectors and governance tensions
